LONDON, March 5 /PRNewswire/ --

- Mandate to Expand Internationally and Develop Product Range

Data Explorers, the specialist independent company that provides the global securities financing industry with analysis, monitoring and decision support tools, today announced the appointment of Donal Smith as Chief Executive Officer.

Smith becomes responsible for the day-to-day management of the Company, with the primary aim of expanding the business internationally and developing the product range available to existing and new customers. The company's founder, Mark Faulkner, will assume the role of Head of Innovation, and Chairman Bill Cuthbert will continue the development of strategic client relationships.

HOUSTON, March 5 /PRNewswire/ --

MADRID, Spain, March 5 /PRNewswire/ --

SolFocus today announced the appointment of Roberto de Diego Arozamena as Managing Director of SolFocus Europe, and Pedro Ladron de Guevara de Echavarria as Vice President and General Manager of the company's Tracking Systems Business Division. These appointments are crucial steps following the November election of the SolFocus Europe board of directors which includes business leader, economist, and Repsol Board member Paulina Beato and Germano Fanelli, Chairman of Arrow EMEASA. The announcement was made by company Chairman Gary D. Conley.

MILPITAS, California, March 5 /PRNewswire/ --

- Appro to Support Renault's Drive for Performance in Formula 1 Racing

Appro (http://www.appro.com), a leading provider of high-performance enterprise computing systems, today announced that it has been awarded a contract for a 38TF Appro Xtreme-X(TM) Supercomputer for the ING Renault F1 Team Computation Fluid Dynamics (CFD) Centre, a brand new modern technology-driven research facility designed to place Renault "in the pole position" in Formula 1 competition. This award marks another milestone for Appro's supercomputers in international HPC markets. The Appro Xtreme-X2 Supercomputer will be shipped and installed by Appro at the Renault F1 CFD Centre in the UK by the end of June, 2008.

PARIS and PRINCETON, New Jersey, March 5 /PRNewswire/ --

- A New Step Forward May Help Increase Appropriate Early Use of Plavix(R) by Simplifying Administration in Acute Coronary Syndrome Patients

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion recommending approval of the 300mg tablet of the antiplatelet Plavix(R) (clopidogrel bisulfate). This positive opinion from the CHMP needs to be ratified by the European Commission in the coming months before final approval.

SINGAPORE, March 5 /PRNewswire/ -- ICIS pricing, http://www.icispricing.com/, the world's leading price reporting service for the global chemical industry, has launched a new daily Xylenes (Asia Pacific) report.

The daily Xylenes (Asia Pacific) report will offer daily spot assessments of isomer grade xylene and paraxylene (PX) written by an experienced aromatics team from ICIS pricing.

The section on isomer grade xylene includes spot CFR NE Asia and FOB Korea price assessments, while the portion dedicated to PX has spot CFR China, CFR Taiwan and FOB Korea price assessments.